Royalty Pharma plc (RPRX) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-10 (expected, time not announced). EPS estimate 1.53, revenue estimate 960.7M.
Over the last 12 reports the stock moved 2.3% on average (either way), rising 7 times and falling 5. EPS beat estimates 10 of 12 times; revenue 4 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-11-04 | 1.21 | 1.18 | +2.5% | 890.0M | 884.8M | +1.8% |
| Q2 FY2026 | 2026-08-05 | 1.32 | 1.27 | +3.9% | 773.0M | 758.9M | -0.4% |
| Q1 FY2026 | 2026-05-06 | 1.30 | 1.21 | +7.4% | 925.0M | 881.7M | -0.5% |
| Q4 FY2025 | 2026-02-11 | 1.46 | 1.29 | +13.2% | 874.0M | 807.0M | +1.3% |
| Q3 FY2025 | 2025-11-05 | 1.17 | 0.99 | +17.7% | 609.3M | 717.4M | +7.8% |
| Q2 FY2025 | 2025-08-06 | 1.14 | 1.03 | +10.7% | 578.7M | 673.0M | -2.4% |
| Q1 FY2025 | 2025-05-08 | 1.06 | 0.95 | +11.2% | 568.2M | 705.3M | +1.2% |
| Q4 FY2024 | 2025-02-11 | 1.15 | 0.99 | +16.2% | 594.0M | 687.1M | +2.0% |